Ramucirumab for advanced hepatocellular carcinoma in the current real world: a Japanese single-arm study post-REACH-2 (The R-evolution study)

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Investigational New Drugs

Topics

Medicine

Cancer Oncology

Internal Medicine

Hepatology

Pathology And Forensic Medicine

Show all topics

DOI

10.1007/s10637-024-01441-3

License

CC-BY

Other Formats

PDF